Keywords: Astellas, Betmiga, Mirabegron, Oceractive bladded. OAB. European Commission

Astellas' Betmiga Oked in EU for overactive bladder

Article | 14 January 2013

The European subsidiary of Japanese drug major Astellas Pharma (TYO: 4503) has received approval from the European Commission for its Betmiga ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Astellas Pharma

Go to company listing

Related Drugs

mirabegron

Betmiga

Go to drug listing